Published online June 2, 2008
PEDIATRICS Vol. 121 No. 6 June 2008, pp. 1127-1136 (doi:10.1542/peds.2007-2392)
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Web of Science (3)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Christo, K.
Right arrow Articles by Misra, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Christo, K.
Right arrow Articles by Misra, M.
Related Collections
Right arrow Adolescent Medicine
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

ARTICLE

Bone Metabolism in Adolescent Athletes With Amenorrhea, Athletes With Eumenorrhea, and Control Subjects

Karla Christo, MDa, Rajani Prabhakaran, MDa,b, Brooke Lamparello, MSa, Jennalee Cord, BAa, Karen K. Miller, MDa, Mark A. Goldstein, MDc, Nupur Gupta, MDc, David B. Herzog, MDd, Anne Klibanski, MDa and Madhusmita Misra, MD, MPHa,b

a Neuroendocrine Unit, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts
b Pediatric Endocrine Unit
c Adolescent Medicine Unit, Mass General Hospital for Children and Harvard Medical School, Boston, Massachusetts
d Harris Center, Massachusetts General Hospital, Boston, Massachusetts

OBJECTIVE. We hypothesized that, despite increased activity, bone density would be low in athletes with amenorrhea, compared with athletes with eumenorrhea and control subjects, because of associated hypogonadism and would be associated with a decrease in bone formation and increases in bone-resorption markers.

METHODS. In a cross-sectional study, we examined bone-density measures (spine, hip, and whole body) and body composition by using dual-energy radiograph absorptiometry and assessed fasting levels of insulin-like growth factor I and bone-turnover markers (N-terminal propeptied of type 1 procollagen and N-telopeptide) in 21 athletes with amenorrhea, 18 athletes with eumenorrhea, and 18 control subjects. Subjects were 12 to 18 years of age and of comparable chronologic and bone age.

RESULTS. Athletes with amenorrhea had lower bone-density z scores at the spine and whole body, compared with athletes with eumenorrhea and control subjects, and lower hip z scores, compared with athletes with eumenorrhea. Lean mass did not differ between groups. However, athletes with amenorrhea had lower BMI z scores than did athletes with eumenorrhea and lower insulin-like growth factor I levels than did control subjects. Levels of both markers of bone turnover were lower in athletes with amenorrhea than in control subjects. BMI z scores, lean mass, insulin-like growth factor I levels, and diagnostic category were important independent predictors of bone mineral density z scores.

CONCLUSIONS. Although they showed no significant differences in lean mass, compared with athletes with eumenorrhea and control subjects, athletes with amenorrhea had lower bone density at the spine and whole body. Insulin-like growth factor I levels, body-composition parameters, and menstrual status were important predictors of bone density. Follow-up studies are necessary to determine whether amenorrhea in athletes adversely affects the rate of bone mass accrual and therefore peak bone mass.


Key Words: adolescents • athletes • bone density • bone-turnover markers • insulin-like growth factor I

Abbreviations: WB—whole-body • BA—bone area • IGF-I—insulin-like growth factor I • BMD—bone mineral density • BMC—bone mineral content • PINP—N-terminal propeptide of type 1 procollagen • BMAD—bone mineral apparent density


Accepted Sep 27, 2007.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
J. Clin. Endocrinol. Metab.Home page
R. F. A. de Lind van Wijngaarden, D. A. M. Festen, B. J. Otten, E. G. A. H. van Mil, J. Rotteveel, R. J. Odink, M. van Leeuwen, D. A. J. P. Haring, G. Bocca, E. C. A. Mieke Houdijk, et al.
Bone Mineral Density and Effects of Growth Hormone Treatment in Prepubertal Children with Prader-Willi Syndrome: A Randomized Controlled Trial
J. Clin. Endocrinol. Metab., October 1, 2009; 94(10): 3763 - 3771.
[Abstract] [Full Text] [PDF]


Home page
JWatch PediatricsHome page
Exercise plus Amenorrhea Equals Thinner Bones
Journal Watch Pediatrics and Adolescent Medicine, August 6, 2008; 2008(806): 1 - 1.
[Full Text]